Katharina Schmid
Clinical Institute of Pathology and Department of Medicine I
Medical University of Vienna
Waehringer Guertel 18-20
Vienna A-1090
Austria
Name/email consistency: high
- EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Schmid, K., Oehl, N., Wrba, F., Pirker, R., Pirker, C., Filipits, M. Clin. Cancer Res. (2009)
- KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Schmid, K., Wang, X., Haitel, A., Sieghart, W., Peck-Radosavljevic, M., Bodingbauer, M., Rasoul-Rockenschaub, S., Wrba, F. Virchows Arch. (2007)
- Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas. Schmid, K., Angerstein, N., Geleff, S., Gschwendtner, A. Mod. Pathol. (2006)
- Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Schmid, K., Birner, P., Gravenhorst, V., End, A., Geleff, S. Am. J. Surg. Pathol. (2005)